ProPhase Labs, Inc. - SIC # 8080 -

Ticker Exchange SIC # Website Latest Ticker
PRPH Nasdaq 8080 www.prophaselabs.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ProPhase Labs, Inc.

ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform - Jun 6th, 2025 5:00 am
ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges - May 21st, 2025 3:00 pm
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 - May 20th, 2025 6:00 am
ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025 - May 13th, 2025 6:00 am
ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Challenges - Apr 3rd, 2025 7:00 am
ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024 - Mar 31st, 2025 6:00 am
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025 - Mar 27th, 2025 6:27 am
Q1 Virtual Investor Summit: On-Demand Presentations Now Live - Mar 18th, 2025 1:30 pm
ProPhase Labs to Present at the Investor Summit Virtual on March 11 - Mar 7th, 2025 6:00 am
Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates - Mar 6th, 2025 3:40 pm
Bears are Losing Control Over ProPhase Labs (PRPH), Here's Why It's a 'Buy' Now - Mar 5th, 2025 7:55 am
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - Feb 26th, 2025 6:00 am
ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs - Feb 25th, 2025 6:00 am
ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables - Feb 20th, 2025 6:00 am
ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports - Feb 18th, 2025 6:00 am
ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm - Jan 22nd, 2025 6:00 am
ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures - Dec 11th, 2024 6:00 am
Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision - Nov 19th, 2024 6:00 am
ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial ... - Nov 18th, 2024 6:01 pm
ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates - Nov 13th, 2024 7:15 am